Cabot Corporation

NYSE:CBT Aktierapport

Börsvärde: US$4.1b

Cabot Tidigare resultatutveckling

Tidigare kriterier kontrolleras 2/6

Cabot har ökat intäkterna med en genomsnittlig årlig takt på 25.8%, medan Chemicals -branschen såg intäkterna minskar på 4% årligen. Intäkterna har varit växande med en genomsnittlig takt på 1.6% per år. Cabot s avkastning på eget kapital är 19.4% och den har en nettomarginal på 7.9%.

Viktig information

25.81%

Tillväxttakt i vinsten

26.74%

Tillväxttakt för EPS

Chemicals Tillväxt i branschen12.93%
Intäkternas tillväxttakt1.65%
Avkastning på eget kapital19.38%
Nettomarginal7.86%
Senaste uppdateringen av resultatet31 Mar 2026

Senaste uppdateringar av tidigare prestationer

Recent updates

Seeking Alpha Mar 26

Cabot: Competitive Pressures Due To High Tire Imports Continuing To Weigh

Summary Cabot Corporation continues to face sustained volume pressure in both Reinforcement Materials and Performance Chemicals, with management candid about ongoing macro headwinds. Despite Battery Materials revenue strength, EBIT in CBT's largest segment dropped by $28 million, and cost-cutting plus reduced capex signal a defensive near-term posture. Earnings are expected to fall by approximately 14% in fiscal 2026, with further downside risk due to recent downward EPS revisions and capacity rationalization plans. Technical analysis suggests the stock is consolidating at best, with broken support levels and weakening momentum likely leading to further downside; we maintain a bearish stance. Read the full article on Seeking Alpha
Analysartikel Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Analysartikel Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Analysartikel Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Analysartikel Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Analysartikel Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysartikel Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Analysartikel Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Analysartikel Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Analysartikel Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysartikel Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysartikel Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Analysartikel Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analysartikel Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...
Analysartikel Oct 07

Improved Earnings Required Before Cabot Corporation (NYSE:CBT) Shares Find Their Feet

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...
Analysartikel Sep 25

Cabot (NYSE:CBT) Is Achieving High Returns On Its Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...
Analysartikel Aug 19

Calculating The Intrinsic Value Of Cabot Corporation (NYSE:CBT)

Key Insights The projected fair value for Cabot is US$96.50 based on 2 Stage Free Cash Flow to Equity With US$99.26...
Seeking Alpha Jul 31

Cabot Corporation: Now A 'Hold' (Rating Downgrade)

Summary Cabot Corporation has seen significant positive performance, up over 44% inclusive of dividends since January 19, 2023. The company has outperformed with good overall investment performance, showing resilience towards macro challenges. Despite recent growth, Cabot is now considered a "Hold" due to valuation concerns and moderate upside potential. Read the full article on Seeking Alpha
Analysartikel Jul 18

Cabot (NYSE:CBT) Will Pay A Dividend Of $0.43

Cabot Corporation's ( NYSE:CBT ) investors are due to receive a payment of $0.43 per share on 13th of September. Based...
Analysartikel Jun 23

Cabot (NYSE:CBT) Looks To Prolong Its Impressive Returns

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analysartikel Jun 09

Why Cabot Corporation (NYSE:CBT) Could Be Worth Watching

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw a double-digit share price...
Analysartikel May 24

Cabot's (NYSE:CBT) Dividend Will Be Increased To $0.43

The board of Cabot Corporation ( NYSE:CBT ) has announced that it will be paying its dividend of $0.43 on the 14th of...
Seeking Alpha May 16

Cabot: Reinforcement Materials Strength To Continue To Drive Earnings Forward

Summary Cabot Corporation's stock has returned approximately 38% since our 'Buy' recommendation in January. The company's Q2 earnings report showed impressive growth in both Performance Chemicals and the Reinforcement Materials business in particular. Cabot's cash flow is driving its financials, allowing for increased dividends and stock buybacks, and its forward-looking fundamentals remain bullish. Read the full article on Seeking Alpha
Analysartikel May 13

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

The market for Cabot Corporation's ( NYSE:CBT ) stock was strong after it released a healthy earnings report last week...
Analysartikel May 10

Cabot's (NYSE:CBT) Upcoming Dividend Will Be Larger Than Last Year's

Cabot Corporation's ( NYSE:CBT ) dividend will be increasing from last year's payment of the same period to $0.43 on...
Analysartikel May 07

Here's Why Cabot (NYSE:CBT) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Fördelning av intäkter och kostnader

Hur Cabot tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.


Resultat- och intäktshistorik

NYSE:CBT Intäkter, kostnader och resultat (USD Millions )
DatumIntäkterIntäkterG+A KostnaderFoU-kostnader
31 Mar 263,57528126256
31 Dec 253,60730626056
30 Sep 253,71332625857
30 Jun 253,81541826360
31 Mar 253,90842626961
31 Dec 243,99141728062
30 Sep 243,99437428163
30 Jun 243,95847028060
31 Mar 243,91044326959
31 Dec 233,92443326059
30 Sep 233,93143725357
30 Jun 234,07830024257
31 Mar 234,25931523758
31 Dec 224,31834824655
30 Sep 224,32120625555
30 Jun 224,11314229056
31 Mar 223,88113030656
31 Dec 213,6319829755
30 Sep 213,40924729356
30 Jun 213,164-5431557
31 Mar 212,765-14429654
31 Dec 202,633-21929257
30 Sep 202,614-23829557
30 Jun 202,7826524654
31 Mar 203,10910326157
31 Dec 193,24312726858
30 Sep 193,33715527060
30 Jun 193,36021728165
31 Mar 193,36927328266
31 Dec 183,3437729567
30 Sep 183,242-11429566
30 Jun 183,115-13628264
31 Mar 182,966-17727961
31 Dec 172,8266926359
30 Sep 172,71724625857
30 Jun 172,61322527053
31 Mar 172,52923426951
31 Dec 162,41920926449
30 Sep 162,41114526648
30 Jun 162,46313625149
31 Mar 162,536-36625652
31 Dec 152,662-38826354
30 Sep 152,871-33627158
30 Jun 153,111-34828158

Kvalitetsintäkter: CBT har inkomster av hög kvalitet.

Växande vinstmarginal: CBT s nuvarande netto vinstmarginaler (7.9%) är lägre än förra året (10.9%).


Fritt kassaflöde vs resultatanalys


Analys av tidigare vinsttillväxt

Resultatutveckling: CBT har blivit lönsamt under de senaste 5 åren och ökat intäkterna med 25.8% per år.

Accelererande tillväxt: CBT s har haft negativ intäktstillväxt under det senaste året, så det kan inte jämföras med dess 5-åriga genomsnitt.

Resultat vs industri: CBT hade negativ intäktstillväxt ( -34% ) under det senaste året, vilket gör det svårt att jämföra med branschens genomsnitt Chemicals ( -1.4% ).


Avkastning på eget kapital

Hög ROE: CBT s avkastning på eget kapital ( 19.4% ) anses vara låg.


Avkastning på tillgångar


Avkastning på sysselsatt kapital


Upptäck starka bolag som tidigare presterat bra

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/20 12:09
Aktiekurs vid dagens slut2026/05/20 00:00
Intäkter2026/03/31
Årlig intjäning2025/09/30

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Cabot Corporation bevakas av 11 analytiker. 5 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank